Smoking cessation Bioresonance therapy smoking cessation bicom2000
Conditions
Interventions
each subject will have one session of a standardized intervention lasting for about 45 minutes using the BICOM2000 device as per the manufactured company protocol that is adopted by Waqf Albarakah Ant
Smoking Charity Clinic. The assessors will be healthcare workers who will get a professional training on the use of bioresonance device in Waqf Albarakah Anti-
Smoking Clinic. Prior to the intervention,
subjects will be asked to consume one cigarette and fill the cigarette ash and its non-
smoked remnants into two glass tubes. Then after,
the glass tubes containing cigarette remnants and ash will be distinctly positioned into the bioresonance device has input electrodes Active bioresonance therapy will be applied via a pre-
set program combination that deliver the electromagnetic waves to the subject over 4 stages.The amplification for the simulated bioresonance therapy (placebo arm) will be set to zero and the input and
so that no oscillation could go in or out the device. The participants will be unable to know which of the treatment variants they will be exposed to since both intervention program combinations will
smoked remnants into t
Experimental Device,Placebo Comparator Device
Sponsors
Investigator
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: subjects for this study will be male cigarette smokers who decide to quit smoking. The study will be restricted to male patients since both centers in which the study will be conducted are designed to serve male patients only. Subjects have to be between 18 and 75 years of age.
Exclusion criteria
Exclusion criteria: Patients who are suffering from heart diseases and/or psychiatric disorders interfering with their insights or judgments, such as schizophrenia or major depression will be excluded. Additionally, Patients who have prior exposure to pharmacological modalities for smoking cessation in the last 3 months will be considered illegible to avoid possible therapeutic contamination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemically confirmed prolonged abstinence rate from smoking 6 Months after the intervention CO level in exhaled air | — |
Secondary
| Measure | Time frame |
|---|---|
| 7-day and 1 month point prevalence abstinence rate from smoking 1 week , 1 month self report | — |
Countries
Saudi Arabia
Contacts
Public ContactHani Almalki
Saudi Board of Community Medicine, department of Community Medicine , College of Medicine , Taibah U
Outcome results
None listed